Rebecca A. Moss

Rebecca A. Moss

Company: Bristol-Myers Squibb

Job title: Clinical Development Lead, Oncology Clinical Development Relatlimab GI


Immuno-Oncology For Early Stage Disease 3:00 pm

Efficacy of IO in late stage/metastatic disease Translating late stage IO efficacy to the adjuvant setting: CheckMate-577 trial Potential for Neoadjuvant IO therapies based on data from Melanoma and Lung cancerRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.